Regional Workshop Economics of Prevention of Non-communicable Diseases (NCD) and Risk Factors (obesity, physical inactivity and poor diets) Mexico City,

Slides:



Advertisements
Similar presentations
noncommunicable diseases
Advertisements

Non Communicable Diseases (NCDs) In Kuwait
Bridget Dillon February 11,  Cardiovascular disease affects the heart and circulatory system. It is often a result of blockages of blood vessels.
Chronic Disease A Public Health Perspective. Chronic Disease Overview The most prevalent, costly, and preventable chronic diseases –cardiovascular disease.
Non Communicable Disease
Chronic Disease A Public Health Perspective Ronald Fischbach, Ph.D.
Chapter Twelve Importance of Noncommunicable Disease.
Coronary Heart Disease (CHD): A Disease of Affluence.
Tt HRB Centre for Health and Diet Research The burden of hypertension Ivan J Perry, Dept. of Epidemiology and Public Health, University College Cork. Institute.
Non-communicable diseases David Redfern
Caribbean Commission on Health & Development FOLLOW UP REPORT OF THE CARIBBEAN COMMISSION ON HEALTH AND DEVELOPMENT Presented to the 27 th Meeting of the.
The National Health Priority Areas
Addressing the Challenge of NCDs in LAC: Brazil Country Case Study Isabella Danel Christoph Kurowski.
National Health Priority Areas (NHPAs). NHPAs Cancer control Cardiovascular disease Injury prevention and control Mental health Arthritis and musculoskeletal.
Terms: Epidemiologic Transition Gaziano 2005 Stage 1Malnutrition and infectious diseases are the leading causes of mortality and morbidity Stage 2Improved.
4 th SIDS Meeting, Sao Tome & Principe April |1 | NCDs in the context of the revised Health Promotion Strategy.
Healthy Living and Diabetes workshop. Content of the workshop Introduction to chronic non-communicable diseases and IPSF activities in the past on that.
NON COMMUNICABLE DISEASES( NCDs) By NSABIMANA Olivier Philemon, B.Pharm. ASEPA / UNR From 19/4-3/5 /2014.
Dr. Joseph Mbatia Assistant Director and Head, NCD, Mental Health and Substance Abuse Ministry of Health and Social Welfare (Tz. Mainland)
The Chronic Disease problem in the Caribbean – civil society perspective Twelfth OECS Health Ministers Meeting, 11 th September 2009 Prof. Trevor A. Hassell.
Promoting Physical Activity in Jamaica Dr Deanna Ashley.
Cardiovascular Disease Healthy Kansans 2010 Steering Committee Meeting April 22, 2005.
Why Stroke Surveillance in the English speaking Caribbean ? Dr. Glennis Andall-Brereton Epidemiologist Caribbean Epidemiology Centre (CAREC/PAHO/WHO)
Meeting the Challenge of Non-Communicable Diseases Lecture 14.
Call to action on NCDs: Challenges and Way Forward for Maternal and Child Health Dr. Niloufer Sultan Ali Professor, Family Medicine Aga Khan University,
The Burden of Chronic Diseases in the Developing World Stephen J. Spann, M.D., M.B.A. Professor and Chairman Department of Family and Community Medicine.
Public Health Agency of Canada Agence de la santé publique du Canada Macroeconomic Impacts of Prevention Policies for NCDs 1 Making the Case to the Finance.
Chronic Disease A Public Health Perspective. Chronic Disease Overview The most prevalent, costly, and preventable chronic diseases –cardiovascular disease.
Cardiovascular Risk: A global perspective
Nick Banatvala & Pascal Bovet
Non-communicable diseases (NCDs) include:
Chronic Non-Communicable Diseases
Noncommunicable Diseases Surveillance in Egypt
NCD policy and programming in Croatia
Chronic NCDs in Sri Lanka : Policy to Public Health approaches
بسم الله الرحمن الرحيم.
2nd International Seminar on the Public Health Aspects of Non-communicable Diseases 10 – 18 August 2010 lausanne, switzerland By Dr D A Bash-Taqi Director.
Outlines towards National NCDs Prevention and Control Strategy
NON-COMMUNICABLE DISEASES – CURRENT SITUATION AND PREVENTION
WHO Surveillance Tools for NCD Risk Factors – Instruments and Data Sources Surveillance and Population-based Prevention Unit Department for Prevention.
DR GHULAM NABI KAZI WHO Country Office Pakistan
Chronic respiratory diseases: burden, population and interventions,
NCD PRESENTATION: JAMAICA
NCD in Bulgaria Assoc. Prof. Plamen Dimitrov, MD, PhD
Health and Human Development
Non-Communicable Diseases Risk Factors Survey in Georgia
Prevention and Control of Noncommunicable Diseases
Georgia NCD Prevention and Control Activities
prevention and control of non communicable diseases in Iraq
Non Communicable Diseases State of Qatar
Cardio- vascular diseases
NCD in Uruguay Ministry of Health Non-communicable Diseases Program
GARD/NCD Action Plan & 2011 UN Summit on NCDs
Racial Disparity in Smoking-Attributable Mortality, Years of Potential Life Lost: Case of Missouri Noaman Kayani, PhD Chronic Disease and Nutrition.
Noncommunicable diseases
Adolescents, Young Adults, and Adults
Non-communicable diseases (NCDs) include:
Prevention Cardiovascular disease
Recognizing Your Risk for Cardiovascular Disease
Non-Communicable Diseases in the Caribbean Region
Cardiovascular Disease (CVD) in Texas
Chapter 8 Adolescents, Young Adults, and Adults
Diabetes in Suriname II PAHO-DOTA Workshop on Quality of Diabetes Care
Heart Disease and Stroke Statistics — 2004 Update
Welcome and Introductions: Tell Us About Yourself
NCD – Kingdom of Saudi Arabia
WHO Statistics, 2000 Dr. Rüdiger Krech
Texas Framework For Heart Disease and Stroke Improved Quality of Life
Dr Timothy Armstrong Coordinator
II PAHO-DOTA Workshop on Quality of Care of Diabetes Care
Presentation transcript:

Regional Workshop Economics of Prevention of Non-communicable Diseases (NCD) and Risk Factors (obesity, physical inactivity and poor diets) Mexico City, November 14-15, 2011 Rainford Wilks Tropical Medicine Research Institute, The UWI Jamaica

Objective To provide an insight into the burden of CNCD (mainly CVD) and risk factors in Jamaica (Data come primarily from National Health Survey of 2008) NB: Data on cancer and respiratory diseases are available and more is being collected but I do not have these today

Global Burden of CNCDs Globally CNCDs account for approximately 60% of all deaths and 43% of the burden of disease* Burden of non-communicable diseases in Caribbean has escalated - accounting for 60% of disease burden * Global Burden of Disease and Risk Factors (WHO)

Leading causes of death in Jamaica over the last 50 years Cause of Death Death Rate Per 100,000 Mean population   Total Male Female Cerebrovascular Diseases 77.9 69.4 86.3 Heart Diseases 76.5 70.9 62.1 Diabetes Mellitus 62.0 47.7 76.2 Hypertensive Diseases 32.1 27.6 36.6 Pneumonia 19.4 20.9 18.0 Cause of Death Death Rate Per 100,000 Mean population   Total Male Female Cerebrovascular Diseases 77.9 69.4 86.3 Heart Diseases 76.5 70.9 62.1 Diabetes Mellitus 62.0 47.7 76.2 Hypertensive Diseases 32.1 27.6 36.6 Pneumonia 19.4 20.9 18.0 Cause of Death Death Rate Per 100,000 Mean population   Total Male Female Cerebrovascular Diseases 77.9 69.4 86.3 Heart Diseases 76.5 70.9 62.1 Diabetes Mellitus 62.0 47.7 76.2 Hypertensive Diseases 32.1 27.6 36.6 Pneumonia 19.4 20.9 18.0  Leading causes of death in Jamaica over the last 50 years This slide shows the Jamaican disease transition so that in 1996, the leading causes of deaths were CNCDs Statistical Institute Of Jamaica

Leading Causes of Death (Jamaica) - 1 1998 1996 Disease # Rate # Rate Cerebrovasc dis. (1) 98.8 (1) 109.0 Diabetes mellitus (2) 56.2 (2) 53.3 Isch.Heart Dis. (3) 50.5 (3) 51.2 Hyperten. Dis. (4) 39.8 (4) 42.3 The next 2 slides, courtesy of Dr. McCaw-Binns and her colleagues, show the leading causes of death in 1998 in 1998, from data which multiple sources of detection rather than just relying on data from the Registrar General’s Report. This shows that CNCDs and CVDs in particular, are by far the leading causes of death in Jamaica. McCaw-Binns et al (under review)

Leading Causes of Death (Jamaica) - 2 1998 1996 Disease # Rate # Rate HIV disease (6) 23.9 (11) 15.8 Homicide/assault (5) 31.3 (5) 31.6 Heart failure (7) 20.9 (7) 21.0 Acute resp. infections (8) 19.0 (6) 21.6 Chronic lower resp (9) 8.8 (8) 18.0 Pulm.& other heart dis. (10) 18.4 (10) 16.8 McCaw-Binns et al (under review)

CVD Risk Factors in Jamaica Jamaican Healthy Lifestyle Survey 2007-2008 (15-74 yrs old)* showed prevalence estimate of Hypertension 25.5% Diabetes mellitus 7.9% Obesity 25.3% Salt added at table 6.1% These health conditions are associated with a high economic cost ** *Wilks et al 2009, **Ward E and Grant A, 2003 *http://www.mona.uwi.edu/reports/health/JHLSII_final_may09.pdf;

Sex Specific Prevalence (%) of CNCDs

Methods of Protein Preparation

Fruits and Vegetables Consumption among Jamaicans

Physical Activity Levels by Sex (%)

Prevalence of Nutritional status by Sex

Prevalence(%) of hypertension by BMI

Prevalence (%) of Diabetes by BMI

Prevalence(%) of High Cholesterol by BMI

Awareness, Treatment & Control Levels (%) Male Female Total Hypertension Aware Treatment Control 30.6 21.0 31.2 69.6 57.8 44.9 50.7 40.0 41.4 Diabetes 73.2 66.4 46.8 78.0 74.9 42.1 76.1 71.5 43.9 High Cholesterol 16.6 13.8 88.4 12.7 9.9 68.5 14.0 11.2 76.3

Alcohol and Substance Use Risk Behaviour Male Female Total Alcohol Use Current Past 80.1 4.0 49.2 3.9 64.3 3.0 Marijuana Use 22.9 22.3 4.4 10.0 13.5 16.0 Cigarette Smoking 22.1 23.0 7.2 10.8 14.5 16.8

Prevalence of Self-reported HA & Stroke in JHLS-II Overall Prevalence Heart Attack Stroke Percentage % 95% CI 0.65 [0.35 -1.21] 1.37 [1.00-1.88 Number of Persons 11839 [4575-19000] 25000 [17000-33000] Age categories 15-34 0.34 [0.08-1.45] 0.45 [0.17-1.21] 35-54 0.29 [0.06-1.28] 1.31 [0.68-2.52] 55-74 2.56 [1.20-5.38 4.50 [3.02-6.65] Ferguson et al. 2010

COST OF CHRONIC DISEASES Cost Item Diabetes (J$) Hypertension (J$) Direct Cost (2002) Hospitalization 135,464,269 (8%) 84,753,708 (7%) Clinic/Doctor’s Visits 332,500,000 (21%) 415,652,000 (33%) Drugs 113,800,284 (7%) 203,519,628 (16%) Laboratory/Diagnostic Tests 873,487,154 (54%) 357,847,984 (29%) Indirect Cost (2002) Productivity Loss 156,291,630 (10%) 186,339,706 (15%) Total Economic Burden 1,611,543,337 1,248,140,027 This was a study done by the Ministry of Health

Estimated Economic Burden ($US Million, 2001) BAH BAR JAM TRT Diabetes 27.3 37.8 208.8 494.4 Hypertension 46.4 72.7 251.6 259.5 Total 76.7 110.5 460.4 753.9 We have data for four of our countries on what it would cost to treat diabetes and hypertension adequately. The cost is staggering. In Jamaica it would be 460 million dollars-and that was in 2001. The cost would undoubtedly be much higher now. These data were provided by Dr.O Abdullahi Abdulkadri

Country: National level policies implemented Aimed to reduce the prevalence of chronic diseases (breast cancer, colo-rectal cancer, cardiovascular disease, diabetes, hypertension, other NCDs). Target population and year of implementation. Intended to modify behaviors: Alcoholism Tobacco Unhealthy diets Physical inactivity Salt National Strategic Plan for the Promotion of Healthy Lifestyles In Jamaica 2004-2008 - Addressed most issues listed - Current status uncertain

Summary Jamaica, like many middle income countries have a large burden of CNCD risk factors The response to this scenario is sub-optimal There are gaps in the situational analysis especially with respect to cancer and respiratory diseases but the former is being addressed There are gaps in capacity, in particular health economics There is a foundation on which to build and participate in initiatives such as this Workshop proposes

Country: JAMAICA Basic statistics about Noncommunicable Diseases (NCD) Burden of disease, available year and source. Mortality rate, available year and source. Prevalence of NCD, available year and source. Indirect and direct costs, available studies and source. Costs for medical attention. Taller Regional Economía de la prevención de ECNT y FR Ciudad de México, 14-15 de Noviembre del 2011 Regional workshop Economics of Prevention of NCD and RF Mexico City, 14-15 November 2011

Country: Health Systems topics Epidemiologic Surveillance. - National Surveys, 2001 & 2008. Next planned for 2015 Provider of health services. Medical units detection. Nutritional counseling units. Medical attention primary care. Medical attention specialized services. Financing resources for specific NCD programs available. Human resources specialized in NCDs prevention and treatment. Taller Regional Economía de la prevención de ECNT y FR Ciudad de México, 14-15 de Noviembre del 2011 Regional workshop Economics of Prevention of NCD and RF Mexico City, 14-15 November 2011

Country: Research in economic evaluation of NCDs Studies developed or commisioned by MoH, objectives, information used, year and main results. Basic economic information, including year and source of available information: Average wage Average monetary income (from household surveys) Availability of paid sick leave Level of sickness leave

Key questions for the future work What are the obstacles, in terms of methodology and availability of information, to estimate the net impact of NCDs on economic variables? What characteristics (variables, conditions) do data collection methods need to consider in order to capture these effects? What statistical methods are most appropriate for the purpose? What are the direct and indirect costs incurred by national health systems as a result of NCDs? Is there an association between the magnitude of the impact and the structure of the model of care? What are the implications of potential cost increases from the rising prevalence of NCDs in the Region for the financing and structure of health systems? What are the links between NCDs on the one hand, and development, economic growth rates and human capital accumulation (e.g., lost productivity due to disability, decline in labor supply, premature mortality, etc.) on the other? What are the long-term advantages of investing to expand prevention measures to achieve overall improvements in health? (See Technical Note as reference)